Matrix Biologics Inc.

Matrix Biologics is a provider-first regenerative medicine distribution company specializing in FDA-approved biologic products and intelligent compliance infrastructure. The company combines Matrix-Accredited biologic sourcing with AI-powered safety, compliance, and outcomes intelligence (Integrated Safety Intelligence™) to serve medical and wellness providers, clinics, provider networks, and clinical research organizations. Matrix Biologics offers premium regenerative biologic products—including exosomes—with competitive provider-first pricing, clinical documentation support, real-world outcomes tracking, and CME-accredited education. The platform integrates regulatory pathway alignment, safety and risk profiling, consent workflows, and research-ready infrastructure to enable providers to scale regenerative medicine programs responsibly while maintaining transparency and long-term patient outcomes focus.